|
Name |
(1R,3S,7R,8E,11S,12R)-1,4-dimethyl-12-[(2R,3Z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradeca-4,8-diene-8-carbaldehyde
|
| Molecular Formula | C25H34O2 | |
| IUPAC Name* |
(1R,3S,7R,8E,11S,12R)-1,4-dimethyl-12-[(2R,3Z)-6-methylhepta-3,5-dien-2-yl]-6-oxotricyclo[9.3.0.03,7]tetradeca-4,8-diene-8-carbaldehyde
|
|
| SMILES |
CC1=CC(=O)[C@@H]/2[C@@H]1C[C@]3(CC[C@@H]([C@@H]3C/C=C2/C=O)[C@H](C)/C=C\C=C(C)C)C
|
|
| InChI |
InChI=1S/C25H34O2/c1-16(2)7-6-8-17(3)20-11-12-25(5)14-21-18(4)13-23(27)24(21)19(15-26)9-10-22(20)25/h6-9,13,15,17,20-22,24H,10-12,14H2,1-5H3/b8-6-,19-9-/t17-,20-,21-,22+,24+,25-/m1/s1
|
|
| InChIKey |
RKNMPQSLAZUFIT-MNZSMBGHSA-N
|
|
| Synonyms |
6-epi-Ophiobolin G
|
|
| CAS | NA | |
| PubChem CID | 102332996 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 366.5 | ALogp: | 5.8 |
| HBD: | 0 | HBA: | 2 |
| Rotatable Bonds: | 4 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 34.1 | Aromatic Rings: | 3 |
| Heavy Atoms: | 27 | QED Weighted: | 0.454 |
| Caco-2 Permeability: | -4.629 | MDCK Permeability: | 0.00001900 |
| Pgp-inhibitor: | 0.982 | Pgp-substrate: | 0.006 |
| Human Intestinal Absorption (HIA): | 0.032 | 20% Bioavailability (F20%): | 0.737 |
| 30% Bioavailability (F30%): | 0.022 |
| Blood-Brain-Barrier Penetration (BBB): | 0.018 | Plasma Protein Binding (PPB): | 96.42% |
| Volume Distribution (VD): | 2.533 | Fu: | 3.29% |
| CYP1A2-inhibitor: | 0.946 | CYP1A2-substrate: | 0.67 |
| CYP2C19-inhibitor: | 0.937 | CYP2C19-substrate: | 0.867 |
| CYP2C9-inhibitor: | 0.923 | CYP2C9-substrate: | 0.038 |
| CYP2D6-inhibitor: | 0.967 | CYP2D6-substrate: | 0.022 |
| CYP3A4-inhibitor: | 0.958 | CYP3A4-substrate: | 0.811 |
| Clearance (CL): | 4.86 | Half-life (T1/2): | 0.151 |
| hERG Blockers: | 0.538 | Human Hepatotoxicity (H-HT): | 0.352 |
| Drug-inuced Liver Injury (DILI): | 0.316 | AMES Toxicity: | 0.042 |
| Rat Oral Acute Toxicity: | 0.244 | Maximum Recommended Daily Dose: | 0.912 |
| Skin Sensitization: | 0.952 | Carcinogencity: | 0.815 |
| Eye Corrosion: | 0.012 | Eye Irritation: | 0.127 |
| Respiratory Toxicity: | 0.978 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC005803 | ![]() |
0.783 | D0V2JK | ![]() |
0.265 | ||
| ENC002981 | ![]() |
0.708 | D06AEO | ![]() |
0.250 | ||
| ENC003783 | ![]() |
0.685 | D04GJN | ![]() |
0.246 | ||
| ENC002000 | ![]() |
0.685 | D0P0HT | ![]() |
0.237 | ||
| ENC003777 | ![]() |
0.685 | D04SFH | ![]() |
0.235 | ||
| ENC002982 | ![]() |
0.606 | D0F1UL | ![]() |
0.232 | ||
| ENC002983 | ![]() |
0.515 | D0D2TN | ![]() |
0.225 | ||
| ENC005044 | ![]() |
0.500 | D0I2SD | ![]() |
0.224 | ||
| ENC005045 | ![]() |
0.485 | D04ATM | ![]() |
0.222 | ||
| ENC003687 | ![]() |
0.467 | D07BSQ | ![]() |
0.221 | ||